BCYC
Price
$8.61
Change
-$0.06 (-0.69%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
595.58M
6 days until earnings call
PPBT
Price
$2.73
Change
+$0.06 (+2.25%)
Updated
Apr 24, 04:58 PM (EDT)
Capitalization
7.01M
Ad is loading...

BCYC vs PPBT

Header iconBCYC vs PPBT Comparison
Open Charts BCYC vs PPBTBanner chart's image
Bicycle Therapeutics
Price$8.61
Change-$0.06 (-0.69%)
Volume$15.36K
Capitalization595.58M
Purple Biotech
Price$2.73
Change+$0.06 (+2.25%)
Volume$190
Capitalization7.01M
BCYC vs PPBT Comparison Chart
Loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PPBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCYC vs. PPBT commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Buy and PPBT is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (BCYC: $8.60 vs. PPBT: $2.73)
Brand notoriety: BCYC and PPBT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 87% vs. PPBT: 48%
Market capitalization -- BCYC: $595.58M vs. PPBT: $7.01M
BCYC [@Biotechnology] is valued at $595.58M. PPBT’s [@Biotechnology] market capitalization is $7.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green whilePPBT’s FA Score has 2 green FA rating(s).

  • BCYC’s FA Score: 1 green, 4 red.
  • PPBT’s FA Score: 2 green, 3 red.
According to our system of comparison, PPBT is a better buy in the long-term than BCYC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 4 TA indicator(s) are bullish while PPBT’s TA Score has 4 bullish TA indicator(s).

  • BCYC’s TA Score: 4 bullish, 4 bearish.
  • PPBT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BCYC is a better buy in the short-term than PPBT.

Price Growth

BCYC (@Biotechnology) experienced а +16.37% price change this week, while PPBT (@Biotechnology) price change was -3.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

BCYC is expected to report earnings on Jul 31, 2025.

PPBT is expected to report earnings on Mar 10, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCYC($596M) has a higher market cap than PPBT($7.01M). BCYC YTD gains are higher at: -38.071 vs. PPBT (-41.791). PPBT has higher annual earnings (EBITDA): -7.05M vs. BCYC (-164.89M). BCYC has more cash in the bank: 880M vs. PPBT (8.52M). PPBT has less debt than BCYC: PPBT (183K) vs BCYC (9.49M). BCYC has higher revenues than PPBT: BCYC (35.3M) vs PPBT (0).
BCYCPPBTBCYC / PPBT
Capitalization596M7.01M8,502%
EBITDA-164.89M-7.05M2,338%
Gain YTD-38.071-41.79191%
P/E RatioN/A0.05-
Revenue35.3M0-
Total Cash880M8.52M10,324%
Total Debt9.49M183K5,187%
FUNDAMENTALS RATINGS
BCYC vs PPBT: Fundamental Ratings
BCYC
PPBT
OUTLOOK RATING
1..100
1929
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
33
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8792
PRICE GROWTH RATING
1..100
8964
P/E GROWTH RATING
1..100
10012
SEASONALITY SCORE
1..100
n/a27

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BCYC's Valuation (24) in the null industry is in the same range as PPBT (33) in the Pharmaceuticals Major industry. This means that BCYC’s stock grew similarly to PPBT’s over the last 12 months.

BCYC's Profit vs Risk Rating (100) in the null industry is in the same range as PPBT (100) in the Pharmaceuticals Major industry. This means that BCYC’s stock grew similarly to PPBT’s over the last 12 months.

BCYC's SMR Rating (87) in the null industry is in the same range as PPBT (92) in the Pharmaceuticals Major industry. This means that BCYC’s stock grew similarly to PPBT’s over the last 12 months.

PPBT's Price Growth Rating (64) in the Pharmaceuticals Major industry is in the same range as BCYC (89) in the null industry. This means that PPBT’s stock grew similarly to BCYC’s over the last 12 months.

PPBT's P/E Growth Rating (12) in the Pharmaceuticals Major industry is significantly better than the same rating for BCYC (100) in the null industry. This means that PPBT’s stock grew significantly faster than BCYC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCYCPPBT
RSI
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
70%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 8 days ago
78%
Declines
ODDS (%)
Bearish Trend 8 days ago
86%
Bearish Trend 16 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PPBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SGMA1.250.19
+17.92%
SigmaTron International
ULBI4.580.14
+3.15%
Ultralife Corp
DGX175.872.30
+1.33%
Quest Diagnostics
MGEE90.78-0.25
-0.27%
MGE Energy
SPTN20.44-0.08
-0.39%
SpartanNash Company

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with INO. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
-0.69%
INO - BCYC
52%
Loosely correlated
+0.81%
RPTX - BCYC
49%
Loosely correlated
-6.57%
XNCR - BCYC
48%
Loosely correlated
+2.07%
RLAY - BCYC
48%
Loosely correlated
+6.14%
FHTX - BCYC
41%
Loosely correlated
+10.38%
More

PPBT and

Correlation & Price change

A.I.dvisor indicates that over the last year, PPBT has been loosely correlated with SNTI. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if PPBT jumps, then SNTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PPBT
1D Price
Change %
PPBT100%
+2.16%
SNTI - PPBT
55%
Loosely correlated
+9.93%
BCYC - PPBT
32%
Poorly correlated
-0.81%
VERV - PPBT
31%
Poorly correlated
+5.67%
ORYZF - PPBT
29%
Poorly correlated
N/A
IMUX - PPBT
28%
Poorly correlated
+3.64%
More